What is Leerink Partnrs’ Estimate for ALDX Q2 Earnings?
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for Aldeyra Therapeutics in a note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman forecasts that the biotechnology company will earn ($0.23) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ […]
More Stories
Here Are the Countries That Have Reached, or Are Considering, Deportation Deals With US
By Savannah Hulsey Pointer President Donald Trump’s illegal immigrant deportation push has officials looking for new places to put illegal...
Focus Partners Wealth Invests $193,000 in D-Wave Quantum Inc. (NYSE:QBTS)
Focus Partners Wealth purchased a new position in D-Wave Quantum Inc. (NYSE:QBTS – Free Report) during the 4th quarter, Holdings...
Sanford C. Bernstein Cuts Palo Alto Networks (NASDAQ:PANW) Price Target to $225.00
Palo Alto Networks (NASDAQ:PANW – Free Report) had its target price cut by Sanford C. Bernstein from $229.00 to $225.00...
Home Depot (NYSE:HD) Upgraded at Stifel Nicolaus
Stifel Nicolaus upgraded shares of Home Depot (NYSE:HD – Free Report) from a hold rating to a buy rating in...
Deutsche Bank AG Acquires 15,258 Shares of Enerpac Tool Group Corp. (NYSE:EPAC)
Deutsche Bank AG raised its holdings in shares of Enerpac Tool Group Corp. (NYSE:EPAC – Free Report) by 45.8% during...
Janus Henderson Group PLC Has $888,000 Stock Position in GFL Environmental Inc. (NYSE:GFL)
Janus Henderson Group PLC reduced its holdings in shares of GFL Environmental Inc. (NYSE:GFL – Free Report) by 77.0% in...